Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Increased prevalence of type 2 diabetes-related complications in combined type 2 diabetes and sickle cell trait
source: Diabetes care
year: 2018
authors: Skinner SC, Diaw M, Pialoux V, Mbaye MN, Mury P, Lopez P, Bousquet D, Gueye F, Diedhiou D, Joly P, Renoux C, Sow D, Diop S, Ranque B, Vinet A, Samb A, Guillot N, Connes P
summary/abstract:Objective:
The prevalence of type 2 diabetes (T2D) is rapidly increasing in sub-Saharan Africa, where sickle cell trait (SCT) is also frequent. Although SCT is generally considered a benign condition, evidence suggests that SCT could exaggerate vascular dysfunction in T2D. However, it remains unclear whether SCT could increase the risk of the development of T2D complications. Therefore, this study was conducted to determine whether T2D complications were more prevalent among Senegalese individuals with SCT and T2D than among those with T2D only.
Research Design and Methods:
Rates of hypertension, retinopathy, peripheral neuropathy, peripheral artery disease, and impaired renal function as well as arterial stiffness, blood rheology, and concentrations of plasma advanced glycation end products (AGEs) and cytokines were compared between groups of Senegalese individuals with combined SCT and T2D (T2D-SCT) (n = 60), T2D (n = 52), SCT (n = 53), and neither T2D nor SCT (control) (n = 56). Human aortic endothelial cell (HAEC) expression of inflammatory and adhesion factors was measured after treatment with tumor necrosis factor-α and subjects’ plasma. Effects of AGE inhibition or tiron on HAEC expression of E-selectin were measured.
Results:
Retinopathy, hypertension, and reduced renal function were more prevalent, and arterial stiffness, blood viscosity at high shear rates, and thixotropic index were higher, in the SCT group compared with the other groups. Multivariable analysis showed that plasma AGE concentration was significantly associated with arterial stiffness. E-selectin expression was elevated in HAECs treated with T2D-SCT plasma compared with the other groups, but AGE inhibition reversed this.
Conclusions:
SCT could potentially augment the risk of the development of T2D-related complications, including retinopathy, nephropathy, and hypertension.
DOI: 10.2337/dc18-1289
read more full text
Related Content
-
Ty Montgomery says he’s not worried about sickle cell traitThe symptoms that kept Ty Montgomery out...
-
Association among sickle cell trait, fitness, and cardiovascular risk factors in CARDIAThe contribution of sickle cell trait (S...
-
For Patients: Sickle Cell TraitSickle cell trait is an inherited blood ...
-
Malaria-Driven Sickle Cell Trait Selection – Evidence for Modern Day Human Evolution?Sickle cell disease poses a serious heal...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
-
With Cincinnati Children’s Hospital – What is Sickle Cell Trait?https://www.youtube.com/watch?v=MDepyJP5...
-
Cardinals’ Bruce Arians: WR John Brown carries sickle-cell traitA blood test Thursday revealed that Ariz...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.